Macrolide-resistant Streptococcus pneumoniae on the islands of Gran Canaria and Lanzarote (Spain): Molecular mechanisms and serogroup relationships;Resistencia antibiótica a los macrólidos en Streptococcus pneumoniae en las islas de Gran Canaria y Lanzarote: Mecanismos moleculares y relación con serogrupos

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 25, Issue 9, 2007, Pages 570-575

  Artiles, Fernando ^a   Horcajada Herrera, Iballa ^a   Noguera Catalán, Javier ^a   Álamo Antúnez, Isabel ^a   Bordes Benítez, Ana ^a   Lafarga Capuz, Bernardo ^a  

^a HOSPITAL UNIVERSITARIO DE CANARIAS   (Spain)

Author keywords

Canary Islands; Macrolide resistance; Streptococcus pneumoniae

Indexed keywords

COTRIMOXAZOLE; MACROLIDE; PENICILLIN G; TELITHROMYCIN; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATION; BLOOD GROUP TYPING; DRUG MECHANISM; ERMB GENE; GENE; GENE ISOLATION; GENOTYPE; HUMAN; MACROLIDE RESISTANT STREPTOCOCCUS PNEUMONIAE; MEFA GENE; MEFE GENE; PHENOTYPE; POLYMERASE CHAIN REACTION; SPAIN; STREPTOCOCCUS PNEUMONIAE;

EID: 35948978457     PISSN: 0213005X     EISSN: 15781852     Source Type: Journal    
DOI: 10.1157/13111183     Document Type: Article

References (27)

1. Whitney C, Farley M, Hadler J, Harrison L, Lexau C, Reingold A, et al. Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States. N Engl J Med. 2000;343:1917-24.
2. European Antimicrobial Resistance Surveillance System (EARSS). Disponible en: http://www.rivm.nl/earss/.
3. Gruneberg RN. Global surveillance through PROTEKT: the first year. J Chemother. 2002;14:9-16.
4. Farrell D, Morrissey I, Bakker S, Buckridge S, Felmingham D. In vitro activities of telithromycin, linezolid, and quinupristin-dalfopristin against Streptococcus pneumoniae with macrolide resistance due to ribosomal mutations. Antimicrob Agents Chemother. 2004;48:3169-71.
5. Reinert RR, Ringelstein A, Van der Linden M, Yücel M, Al-Lahham A, Schmitz FJ. Molecular epidemiology of macrolide-resistant Streptococcus pneumoniae isolates in Europe. J Clin Microbiol. 2005;43:1294-300.
6. Pérez-Trallero E, Fernández-Mazarrasa C, García-Rey C, Bouza E, Aguilar L, García-de-Lomas J, et al. Antimicrobial susceptibilities of 1684 Streptococcus pneumoniae and 2039 Streptococcus pyogenes isolates and their ecological relationships: results of a 1-year (1998-1999) multicenter surveillance study in Spain. Antimicrob Agents Chemother. 2001;45:3334-40.
7. Farrell D, Morrissey I, Bakker S, Felmingham D. Molecular characterization of macrolide resistance mechanisms among Streptococcus pneumoniae and Streptococcus pyogenes isolated from the PROTEKT 1999-2000 study. J Antimicrob Chemother. 2002;50 Suppl 1:39-47.
8. McEllistrem MC, Adams JM, Shutt K, Sanza LT, Facklam RR, Whitney CG, et al. Erythromycin-nonsusceptible Streptococcus pneumoniae in children 1999-2001. Emerg Infect Dis. 2005;11:1-8.
9. Wierzbowski AK, Swedlo D, Boyd D, Mulvey M, Nichol KA, Hoban DJ, et al. Molecular epidemiology and prevalence of macrolide efflux genes mef(A) and mef(B) in Streptococcus pneumoniae obtained in Canada from 1997 to 2002. J Clin Microbiol. 2005;49:1257-61.
10. Nuermberger E, Bishai WR. The clinical significance of macrolide-resistant Streptococcus pneumoniae: It's all relative. Clin Infect Dis. 2004;38:99-103.00
11. Clinical Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing, 15th informational supplement M100-S15. CLSI, 2005.
12. Amezaga MR, Carter P, Cash P, McKenzie H. Molecular epidemiology of erythromycin resistance in Streptococcus pneumoniae isolates from blood and noninvasive sites. J Clin Microbiol. 2002;40:3313-8.
13. Slotved HC, Kaltoft M, Skovsted IC, Kern MB, Espersen F. Simple, rapid latex agglutination test for serotypins of pneumococci (Pneumotest-Latex). J Clin Microbiol. 2004;42:2518-22.
14. Franco-Álvarez F, Causse M, Ibarra A, Rodríguez FC, Casal M. Streptococcus pneumoniae: resistencia antibiótica y serotipos en un período de dos años. Rev Esp Quimioter. 2005;18:217-21.
15. Dicuonzo G, Gherardi G, Gertz RE, D'Ambrosio F, Goglio A, Lorino G, et al. Genotypes of invasive pneumococcal isolates recently recovered from Italian patients. J Clin Microbiol. 2002;40:3660-5.
16. Doit C, Loukil C, Geslin P, Bingen E. Phenotypic and genetic diversity of invasive pneumococcal isolates recovered from French children. J Clin Microbiol. 2002;40:2994-8.
17. Shackley F, Knox K, Bowen J, Crook D, Griffiths D, Mayon-White R, et al. Outcome fo invasive pneumococcal disease: a UK based study. Arch Dis Child. 2000;83:231-3.
18. Gertz R, McEllistrem MC, Boxrud DJ, Li Z, Sakota V, Thompson TA, et al. Clonal distribution of invasive pneumococcal isolates from children and selected adults in the United States prior to 7-valent conjugate vaccine introduction. J Clin Microbiol. 2003;41:4194-216.
19. Littauer P, Sangvik M, Caugant DA, Hoiby EA, Simonsen GS, Sundsfjord A, et al. Molecular epidemiology of macrolide-resistant isolates of Streptococcus pneumoniae collected from blood and respiratory specimens in Norway. J Clin Microbiol. 2005;43:2125-32.
20. Henriques B, Kallin M, Örtqvist A, Olsson B, Almela M, Marrie TJ, et al. Molecular epidemiology of Streptococcus pneumoniae causing invasive disease in 5 countries. J Infect Dis. 2000;182:833-9.
21. García C, Aguilar L, Baquero F, Casal J, Dal-Ré R. Importance of local variation in antibiotic consumption and geographical differences of erythromycin and penicillin resistance in Streptococcus pneumoniae. J Clin Microbiol. 2002;40:159-64.
22. Morosini MI, Cantón R, Loza E, Negri MC, Galán JC, Almaraz F, et al. In vitro activity of telithromycin against Spanish Streptococcus pneumoniae isolates with characterized macrolide resistance mechanisms. J Clin Microbiol. 2001;45:2427-31.
23. Waites KB, Jones KE, Kim KH, Moser SA, Crystal J, Hollingshead S, et al. Dissemination of macrolide-resistant Streptococcus pneumoniae isolates containing both erm(B) and mef(A) in South Korea. J Clin Microbiol. 2003;41:5787-91.
24. Farrell DJ, Morrissey I, Bakker S, Morris L, Buckridge S, Felmingham D. Molecular epidemiology of multiresistant Streptococcus pneumoniae with both erm(B)- and mef(A)-mediated macrolide resistance. J Clin Microbiol. 2004;42:764-8.
25. Hyde TB, Gay K, Stephen DS. Macrolide resistance among invasive Streptococcus pneumoniae isolates. JAMA. 2001;286:1857-62.
26. Fenoll A, Jado I, Vicioso D, Pérez A, Casal J. Evolution of Streptococcus pneumoniae serotypes and antibiotic resistance in Spain: Update (1990 to 1996). J Clin Microbiol. 1998;36:3447-54.
27. Baquero F, García-Rodríguez JA, García de Lomas J, Aguilar L, and the Spanish Surveillance Group for Respiratory Tract Pathogens. Antimicrobial resistance of 1,113 Streptococcus pneumoniae isolates from patients with respiratory tract infections in Spain: Results of a year (1996-1997) multicenter surveillance study. Antimicrob Agents Chemother. 1999;43:357-9.